Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sol Schulman

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Journal of Thrombosis and Haemostasis : JTH|January 6, 2021
How the tissue factor-VIIa complex keeps two substrates in the loopSol Schulman
Blood|November 8, 2014
How I treat poisoning with vitamin K antagonistsSol Schulman, Bruce Furie
Journal of Thrombosis and Haemostasis : JTH|July 30, 2025
Plasma peptidomics: cutting coagulation down to sizeMarisa A Brake, Sol Schulman
Journal of Thrombosis and Haemostasis : JTH|September 21, 2023
Periprocedural management of type 2N von Willebrand disease with efanesoctocog alfaJustine H Ryu, Kenneth A Bauer, Sol Schulman
American Journal of Hematology|August 14, 2012
Neutrophil-erythrocyte rosettes in autoimmune hemolytic anemiaSol Schulman, Mark M Awad, David J Kuter
Seminars in Thrombosis and Hemostasis|May 18, 2023
Human Genetic Variation in F3 and Its Impact on Tissue Factor-Dependent DiseaseJin K Park, Marisa A Brake, Sol Schulman
Proceedings of the National Academy of Sciences of the United States of America|August 11, 2010
Vitamin K epoxide reductase prefers ER membrane-anchored thioredoxin-like redox partnersSol Schulman, Belinda Wang, Weikai Li, et al.
British Journal of Haematology|January 21, 2017
Use of thromboelastography in the management of a patient with acquired von Willebrand disease undergoing cardiac bypass surgeryMoritz Stolla, Sherry Chang, Sol Schulman, et al.
Molecular Cell|May 29, 2007
The plug domain of the SecY protein stabilizes the closed state of the translocation channel and maintains a membrane sealWeikai Li, Sol Schulman, Dana Boyd, et al.
Nature|January 30, 2010
Structure of a bacterial homologue of vitamin K epoxide reductaseWeikai Li, Sol Schulman, Rachel J Dutton, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Journal of Thrombosis and Haemostasis : JTH|January 6, 2021
How the tissue factor-VIIa complex keeps two substrates in the loopSol Schulman
Blood|November 8, 2014
How I treat poisoning with vitamin K antagonistsSol Schulman, Bruce Furie
Journal of Thrombosis and Haemostasis : JTH|July 30, 2025
Plasma peptidomics: cutting coagulation down to sizeMarisa A Brake, Sol Schulman
Journal of Thrombosis and Haemostasis : JTH|September 21, 2023
Periprocedural management of type 2N von Willebrand disease with efanesoctocog alfaJustine H Ryu, Kenneth A Bauer, Sol Schulman
American Journal of Hematology|August 14, 2012
Neutrophil-erythrocyte rosettes in autoimmune hemolytic anemiaSol Schulman, Mark M Awad, David J Kuter
Seminars in Thrombosis and Hemostasis|May 18, 2023
Human Genetic Variation in F3 and Its Impact on Tissue Factor-Dependent DiseaseJin K Park, Marisa A Brake, Sol Schulman
Proceedings of the National Academy of Sciences of the United States of America|August 11, 2010
Vitamin K epoxide reductase prefers ER membrane-anchored thioredoxin-like redox partnersSol Schulman, Belinda Wang, Weikai Li, et al.
British Journal of Haematology|January 21, 2017
Use of thromboelastography in the management of a patient with acquired von Willebrand disease undergoing cardiac bypass surgeryMoritz Stolla, Sherry Chang, Sol Schulman, et al.
Molecular Cell|May 29, 2007
The plug domain of the SecY protein stabilizes the closed state of the translocation channel and maintains a membrane sealWeikai Li, Sol Schulman, Dana Boyd, et al.
Nature|January 30, 2010
Structure of a bacterial homologue of vitamin K epoxide reductaseWeikai Li, Sol Schulman, Rachel J Dutton, et al.
Pageof 3